Obstetric and Early Neonatal Outcomes Following Second and Third COVID-19 Vaccination in Pregnancy
CONCLUSIONS: Compared to the first two doses of the BNT162b2 vaccine given in pregnancy, the booster vaccination is safe and not associated with an increased rate of adverse obstetric and early neonatal outcomes.PMID:38420636
Source: The Israel Medical Association Journal - Category: General Medicine Authors: Ravit Peretz-Machluf Mayan Gilboa Shiran Bookstein-Peretz Omri Segal Noam Regev Raanan Meyer Gili Regev-Yochay Yoav Yinon Shlomi Toussia-Cohen Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | General Medicine | Israel Health | Middle East Health | OBGYN | Perinatology & Neonatology | Pfizer | Pregnancy | Study | Vaccines | Women